On December 6, Partner Tom Kurland will speak at The American Conference Institute's 28th Annual Conference on Drug & Medical Device Litigation. Tom will join Sarah Padgitt (Associate General Counsel, Baxter) and Dan Troy (Managing Director, Berkeley Research Group) for a breakout session titled "FDA in the Crosshairs: What Recent Court Activity and State Litigation Over Mifepristone Means for the Future of Agency Deference." The session will explore the potential fallout of the Supreme Court's decision in Dobbs and how it may impact the role of judges in future medical product liability cases.

To learn more, please click here.